[PDF][PDF] Bevacizumab (bev) in combination with capecitabine (cape) for the first-line treatment of elderly patients with metastatic colorectal cancer (mCRC): results of a …

D Cunningham - hematologyandoncology.net
The safety profile for patients treated with bevacizumab was generally consistent with
previously reported data. Patients in the combination arm were more likely to experience an …

[引用][C] Bevacizumab (bev) in combination with capecitabine (cape) for the first-line treatment of elderly patients with metastatic colorectal cancer (mCRC): Results of a …

D Cunningham, I Lang, V Lorusso, J Ocvirk, D Shin… - 2013 - scholarworks.bwise.kr
ScholarWorks@Gachon: Bevacizumab (bev) in combination with capecitabine (cape) for the
first-line treatment of elderly patients with metastatic colorectal cancer (mCRC): Results of a …

[PDF][PDF] Bevacizumab (bev) in Combination With Capecitabine (cape) for the First-Line Treatment of Elderly Patients With Metastatic Colorectal Cancer (mCRC): Results …

D Cunningham - hematologyandoncology.net
The safety profile for patients treated with bevacizumab was generally consistent with
previously reported data. Patients in the combination arm were more likely to experience an …

Bevacizumab (bev) in combination with capecitabine (cape) for the first-line treatment of elderly patients with metastatic colorectal cancer (mCRC): Results of a …

D Cunningham, I Lang, V Lorusso, J Ocvirk, D Shin… - 2013 - ascopubs.org
337 Background: Elderly patients (pts) comprise the majority of pts diagnosed with mCRC,
although they are in general underrepresented in clinical trials. AVEX, an open-label phase …